Equities

Upstream Bio Inc

UPB:NSQ

Upstream Bio Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)26.09
  • Today's Change0.18 / 0.69%
  • Shares traded32.22k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 16:43 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 202320232022
ASSETS
Cash And Short Term Investments11017
Total Receivables, Net0.360.50
Total Inventory----
Prepaid expenses6.440.52
Other current assets, total0.390.23
Total current assets11718
Property, plant & equipment, net0.200.16
Goodwill, net----
Intangibles, net----
Long term investments----
Note receivable - long term----
Other long term assets00.01
Total assets11718
LIABILITIES
Accounts payable1.990.71
Accrued expenses4.534.14
Notes payable/short-term debt00
Current portion long-term debt/capital leases----
Other current liabilities, total----
Total current liabilities6.524.86
Total long term debt00
Total debt00
Deferred income tax----
Minority interest----
Other liabilities, total2.876.95
Total liabilities9.3912
SHAREHOLDERS EQUITY
Common stock0.000.00
Additional paid-in capital4.821.28
Retained earnings (accumulated deficit)(128)(107)
Treasury stock - common----
Unrealized gain (loss)0.020
Other equity, total----
Total equity1086.67
Total liabilities & shareholders' equity11718
Total common shares outstanding5151
Treasury shares - common primary issue00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.